Get ready for a huge flu-shot push as health officials try to rekindle interest in protection against this new influenza strain that, despite plummeting cases, still is threatening lives — even as they reassess just how much more vaccine needs to be shipped.
Drugmaker MedImmune is recalling nearly 5 million doses of swine flu vaccine because the nasal spray appears to lose strength over time, federal health officials announced Tuesday.
The nation's supply of swine flu vaccine will reach 100 million doses by week's end, opening the way for everyone, not just those at highest risk, to get protected.
After weeks of shortages, swine flu vaccine is plentiful enough that nearly half the states now say everyone can get it, not just people in high-risk groups.
Health officials are recalling hundreds of thousands of doses of swine flu vaccine after tests indicated they may not be potent enough to protect against the virus.
Swine flu has sickened about 50 million Americans, and killed about 10,000, according to new estimates released by federal health officials on Thursday.
Pushing Americans to receive swine flu vaccinations, the Obama administration on Monday released a new slate of television and radio ads to counter an illness that already has infected millions.
There's no evidence that the swine flu vaccine is causing any serious side effects, U.S. health officials said Wednesday, in their first report on the safety of the new vaccine.
Two people in China who received swine flu vaccinations died in the past week but at least one death appears unrelated to the vaccine and the other was being investigated.
Swine flu has sickened about 22 million Americans since April and killed nearly 4,000, including 540 children, say startling federal estimates released Thursday.
Some of New York's biggest companies, including Wall Street giants Goldman Sachs and Citigroup, received doses of swine flu vaccine for at-risk employees, drawing criticism that the hard-to-find vaccine is going first to the privileged.